Geron Corporation
GERN
$1.23+3.36%
End of day · as of Oct 15, 2026, 11:15 PM ET
Mkt cap
$878.95M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2026-06-30)
$57.48M
EPS (H1 2026)
$-0.03
Gross Margin (qtr ended 2026-06-30)
N/A
Profit Margin (qtr ended 2026-06-30)
-29.02%
Beta
0.68
Div yield
N/A
Sector
Healthcare
Geron Corporation (GERN) is a biotechnology company listed on US.
Latest reported GERN revenue for 2026-06-30 was $57.5M. Net income was -$16.7M. Revenue was up 10.9% from 2026-03-31 to 2026-06-30. GERN currently screens at market cap $878.9M.
Use this GERN research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full GERN income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Geron Corporation (GERN) is a biotechnology company in the Healthcare sector.
Latest cached Geron Corporation (GERN) revenue for Jun 30, 2026 was $57.5M. Net income was -$16.7M. Statements: https://lician.com/financials/gern
Geron Corporation (GERN) market capitalization is $878.9M on the latest cached snapshot.
Geron Corporation (GERN) cached previous close $1.19; day range $1.20 – $1.23; volume 5,678,176. Session quote: https://lician.com/quote/gern
Geron Corporation (GERN) latest cached earnings event is "GERN earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached GERN filing is 8-K · Jan 12, 2026. Filings: https://lician.com/sec/gern